Patent 11638760 was granted and assigned to Mersana Therapeutics on May, 2023 by the United States Patent and Trademark Office.
The present disclosure relates generally to antibody-drug conjugates comprising pyrrolo[2, 1-c][1, 4]benzodiazepine (PBD) drug moieties. The present disclosure also relates to methods of using these conjugates, e.g., as therapeutics and/or diagnostics.